Moreover, as in the other MPN, somatic mutations are found in epigenetic regulators, ASXL1, TET2, TET3, DNMT3A or in transcription factor, RUNX1 [6,119] which seem to be acquired in the Ph+ cells [120]. Here, ASXL1 is linked to myeloproliferative disorder.